A new insight into the treatment of renal anemia with HIF stabilizer | Renal Replacement Therapy | Full Text
A novel family of small molecule HIF-1 alpha stabilizers for the treatment of diabetic wounds; an integrated in silico, in vitro, and in vivo strategy - RSC Advances (RSC Publishing)
![PDF] Hypoxia-inducible factor-prolyl hydroxylase inhibitors in the treatment of anemia of chronic kidney disease. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/954f37aaed4c29d5041d58192b31cdf86184379a/2-Figure1-1.png "PDF] Hypoxia-inducible factor-prolyl hydroxylase inhibitors in the treatment of anemia of chronic kidney disease. | Semantic Scholar")
PDF] Hypoxia-inducible factor-prolyl hydroxylase inhibitors in the treatment of anemia of chronic kidney disease. | Semantic Scholar
HIF-PHD inhibitors in renal anemia | Update on phase 3 clinical trials
HIF-PHD inhibitors in renal anemia | Update on phase 3 clinical trials
HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond | Nature Reviews Nephrology
The impacts of hypoxia-inducible factor stabilizers on laboratory parameters and clinical outcomes in chronic kidney disease pat
Stabilization of hypoxia-inducible factor ameliorates glomerular injury sensitization after tubulointerstitial injury - ScienceDirect
Frontiers | HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons
The oral hypoxia-inducible factor prolyl hydroxylase inhibitor enarodustat counteracts alterations in renal energy metabolism in the early stages of diabetic kidney disease - Kidney International
Hypoxia-Inducible Factor Stabilizers for Treating Anemia of CKD in: Kidney News Volume 12 Issue 2 (2020)
Hypoxia-inducible factor–prolyl hydroxylase inhibitors in the treatment of anemia of chronic kidney disease - Kidney International Supplements
Anemia of Chronic Kidney Disease: Will New Agents Deliver on Their Promise?
HIF PHI Trials in CKD non-dialysis and dialysis: What do the data really show?
A new insight into the treatment of renal anemia with HIF stabilizer | Renal Replacement Therapy | Full Text
Ap romising novelt herapeutic approach for the treatment of anemia:... | Download Scientific Diagram
HIF-1 as a target for drug development | Nature Reviews Drug Discovery
PCC-Funded Researcher's work on HIF stabilizers wins TIAFT Young Scientist Award for Best Oral Presentation - PCC - Global Anti-Doping Research Grants for Scientists and Researchers
Selectivity of HIF-PH inhibitors: concerns regarding possible off-target effects | Clinical and Experimental Nephrology
Frontiers | HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons
Frontiers | Clinical Potential of Hypoxia Inducible Factors Prolyl Hydroxylase Inhibitors in Treating Nonanemic Diseases
The pro-angiogenic role of hypoxia inducible factor stabilizer FG-4592 and its application in an in vivo tissue engineering chamber model | Scientific Reports
Full article: HIF prolyl hydroxylase inhibitors for anemia
